Dashboard
Manage Tickers

MDXGMIMEDX GROUP, INC.

Nasdaq mimedx.com


$ 7.29 $ 1.15 (18.67 %)    

Wednesday, 01-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 7.31
$ 6.56
$ 0.00 x 0
$ 0.00 x 0
$ 6.35 - $ 7.38
$ 3.79 - $ 9.27
2,280,226
na
1.1B
$ 1.67
$ 7.78
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 10-30-2023 09-30-2023 10-Q
4 08-01-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 03-08-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 07-06-2020 03-31-2019 10-Q
18 07-06-2020 06-30-2019 10-Q
19 07-06-2020 09-30-2019 10-Q
20 07-06-2020 12-31-2019 10-K
21 07-06-2020 03-31-2020 10-Q
22 03-17-2020 12-31-2018 10-K
23 10-31-2017 09-30-2017 10-Q
24 07-31-2017 06-30-2017 10-Q
25 05-01-2017 03-31-2017 10-Q
26 03-01-2017 12-31-2016 10-K
27 11-08-2016 09-30-2016 10-Q
28 08-02-2016 06-30-2016 10-Q
29 05-10-2016 03-31-2016 10-Q
30 02-29-2016 12-31-2015 10-K
31 11-06-2015 09-30-2015 10-Q
32 08-07-2015 06-30-2015 10-Q
33 05-01-2015 03-31-2015 10-Q
34 03-13-2015 12-31-2014 10-K
35 11-10-2014 09-30-2014 10-Q
36 08-11-2014 06-30-2014 10-Q
37 05-12-2014 03-31-2014 10-Q
38 03-04-2014 12-31-2013 10-K
39 11-08-2013 09-30-2013 10-Q
40 08-08-2013 06-30-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-mimedx-group-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on MiMe...
05/01/2024 11:15:01

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MiMedx Group (NASDAQ:MDXG) with a Buy and maintains $11 pr...

mimedx-group-q1-2024-adj-eps-007-beats-004-estimate-sales-84709m-beat-79361m-estimate
MiMedx Group Q1 2024 Adj EPS $0.07 Beats $...
04/30/2024 20:43:06

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by...

the-fda-issued-determination-letter-for-mimedxs-request-for-designation-noting-axiofill-does-not-meet-regulatory-classification-requirements-of-a-human-cell-tissue-or-cellular-or-tissue-based-product
The FDA Issued Determination Letter For Mi...
03/27/2024 12:09:03

Core News & Articles
Tela Bio Announced Sale Of Distribution Ri...
03/20/2024 11:13:48

lake-street-initiates-coverage-on-mimedx-group-with-buy-rating-announces-price-target-of-12
Lake Street Initiates Coverage On MiMedx G...
03/07/2024 16:02:41

Lake Street analyst Brooks O'Neil initiates coverage on MiMedx Group (NASDAQ:MDXG) with a Buy rating and announces Price...

mizuho-maintains-buy-rating-for-mimedx-group-heres-what-you-need-to-know
Mizuho Maintains Buy Rating for MiMedx Gro...
03/01/2024 17:00:35

mizuho-maintains-buy-on-mimedx-group-raises-price-target-to-14
Mizuho Maintains Buy on MiMedx Group, Rais...
03/01/2024 14:48:30

Mizuho analyst Anthony Petrone maintains MiMedx Group (NASDAQ:MDXG) with a Buy and raises the price target from $13 to $14.

mimedx-group-sees-fy24-adj-ebitda-as-a-percent-of-net-sales-above-20
MiMedx Group Sees FY24 Adj. EBITDA As A Pe...
02/28/2024 21:37:29

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
02/28/2024 21:31:07

mimedx-group-q4-2023-adj-eps-004-misses-007-estimate-sales-8683m-beat-8505m-estimate
MiMedx Group Q4 2023 Adj EPS $0.04 Misses ...
02/28/2024 21:05:11

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 ...

recap-mimedx-group-q4-earnings
Recap: MiMedx Group Q4 Earnings
02/28/2024 21:05:10

earnings-scheduled-for-february-28-2024
Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

mimedx-enhanced-its-capital-structure-by-refinancing-its-existing-indebtedness-and-obtaining-additional-borrowing-capacity-the-new-senior-secured-credit-facilities-total-95m-and-is-due-in-january-2029
MiMedx Enhanced Its Capital Structure By R...
01/22/2024 13:05:31

rivian-automotive-reports-weak-delivery-figures-joins-joyy-mimedx-group-and-other-big-stocks-moving-lower-on-tuesday
Rivian Automotive Reports Weak Delivery Fi...
01/02/2024 16:47:08

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

mimedx-announces-receipt-of-fda-warning-letter-for-axiofill-classification-not-related-to-safety-reiterates-2023-full-year-net-sales-and-fourth-quarter-adjusted-ebitda-margin-outlook
MIMEDX Announces Receipt Of FDA Warning Le...
12/29/2023 22:02:37

mimedx-group-says-its-outstanding-95000-shares-of-series-b-convertible-preferred-stock-were-converted-into-shares-as-a-result-of-this-conversion-approximately-30m-common-shares-have-been-added-to-the-companys-share-count
MiMedx Group Says Its Outstanding 95,000 S...
12/28/2023 13:13:24

mimedx-to-highlight-published-data-at-sawc-fall
MIMEDX To Highlight Published Data At SAWC...
11/02/2023 12:22:11

MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced it will sponsor an Innovation Thea...

mizuho-maintains-buy-on-mimedx-group-lowers-price-target-to-12
Mizuho Maintains Buy on MiMedx Group, Lowe...
10/31/2023 16:09:32

Mizuho analyst Anthony Petrone maintains MiMedx Group (NASDAQ:MDXG) with a Buy and lowers the price target from $14 to $12.

mimedx-group-q3-2023-adj-eps-005-beats-004-estimate-sales-8171m-beat-7812m-estimate
MiMedx Group Q3 2023 Adj EPS $0.05 Beats $...
10/30/2023 20:24:53

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by...

earnings-scheduled-for-october-30-2023
Earnings Scheduled For October 30, 2023
10/30/2023 10:11:19

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION